Market Overview

The Global Market for Migraine Drugs - Opportunity Analysis & Industry Forecast to 2025 -


The "Migraine
Drugs Market by Type, Route of Administration, and Distribution Channel
- Global Opportunity Analysis and Industry Forecast, 2018-2025"

report has been added to's

The global migraine drugs market was valued at $1,713 million in 2017,
and is expected to reach $2,190 million by 2025, growing at a CAGR of
3.1% from 2018 to 2025.

Rise in awareness among patients for migraine treatment & prevention,
rapid increase in female population, and surge in prevalence of migraine
drive the growth of the global migraine drugs market. However, side
effects associated with migraine drugs limit the market growth. On the
contrary, growth opportunities in the developing nations and emerging
new therapies for migraine treatment are expected to present
opportunities for the market growth during the forecast period.

Key Benefits

  • This report entails a detailed quantitative analysis of the overall
    market trends from 2017 to 2025 to identify the prevailing
    opportunities along with strategic assessment of the global migraine
    drugs market.
  • Market size and estimations are based on comprehensive analysis of the
    applications and developments in the industry.
  • An in-depth analysis based on region is provided to understand the
    regional market and facilitate the strategic business planning.
  • The development strategies adopted by the key market players are
    enlisted to understand the competitive scenario of the market.

Profiles for:

Key Players

  • Abbott Laboratories
  • Allergan PLC
  • AstraZeneca
  • Eisai Co. Ltd.
  • Endo International PLC
  • GlaxoSmithKline PLC
  • Impax Laboratories
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer Inc.

Other Players

  • Novartis International AG
  • Teva Pharmaceutical Industries Limited
  • Sanofi SA

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Migraine Drugs Market, by Type

Chapter 5: Migraine Drugs Market, by Route of Administration

Chapter 6: Migraine Drugs Market, by Distribution Channel

Chapter 7: Migraine Drugs Market, by Region

Chapter 8: Company Profiles

For more information about this report visit

View Comments and Join the Discussion!